Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
Canadian Journal of Kidney Health and Disease|March 9, 2017
A Randomized Controlled Trial of the Effects of Febuxostat Therapy on Adipokines and Markers of Kidney Fibrosis in Asymptomatic Hyperuricemic Patients With Diabetic NephropathySrinivasan Beddhu, Rebecca Filipowicz, Bin Wang, et al.
Diabetes, Obesity & Metabolism|December 17, 2016
Comparison of exposure response relationship of atrasentan between North American and Asian populationsHiddo J L Heerspink, Hirofumi Makino, Dennis Andress, et al.
Clinical Pharmacology and Therapeutics|December 18, 2020
Individual Atrasentan Exposure is Associated With Long-term Kidney and Heart Failure Outcomes in Patients With Type 2 Diabetes and Chronic Kidney DiseaseJeroen V Koomen, Jasper Stevens, George Bakris, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 9, 2015
Predictors of Atrasentan-Associated Fluid Retention and Change in Albuminuria in Patients with Diabetic NephropathyDonald E Kohan, Hiddo J Lambers Heerspink, Blai Coll, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 2, 2021
The Effect of Atrasentan on Kidney and Heart Failure Outcomes by Baseline Albuminuria and Kidney Function: A <i>Post Hoc</i> Analysis of the SONAR Randomized TrialSimke W Waijer, Ron T Gansevoort, George L Bakris, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2019
Effects of Sevelamer Carbonate in Patients With CKD and Proteinuria: The ANSWER Randomized TrialBarbara Ruggiero, Matias Trillini, Lida Tartaglione, et al.
Kidney International|February 11, 2026
Podocyte derived endothelin-1 and endothelial cell endothelin A receptors are essential for glomerular injury in mouse models of focal segmental glomerulosclerosisLiping Yu, Ubong S Ekperikpe, Hunter W Korsmo, et al.
Diabetes, Obesity & Metabolism|December 27, 2016
The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathyMichelle J Pena, Dick de Zeeuw, Dennis Andress, et al.
JCI Insight|April 8, 2020
Intercalated cell BKα subunit is required for flow-induced K+ secretionRolando Carrisoza-Gaytan, Evan C Ray, Daniel Flores, et al.
JACC. Heart Failure|June 30, 2022
Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart FailureJ David Smeijer, Jeroen Koomen, Donald E Kohan, et al.
Pageof 16